Ranquilon

N/A

Report date: 2025/08/07 20:00:08
NME

Base Information

Drug NameRanquilon
Drug Alias Name6-phenylhexanoyl)glycyl-L-trypatophan amidePh(CH2)5CO-Gly-D-Trp-NH2GB-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin receptors antagonists
TargetsCholecystokinin receptors
Therapy Area/IndicationsAdjustment DisordersNeurastheniaAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesValenta Pharm JscResearch Zakusov Institute of Pharmacology Federal State Budgetary Institution Russian Academy of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesResearch Zakusov Institute of Pharmacology Federal State Budgetary Institution Russian Academy of Medical SciencesValenta Pharm Jsc
Inactive CompaniesN/A
Active IndicationsAdjustment DisordersNeurastheniaAnxiety
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A